The pharmaceutical community is excited by retatrutide, a novel dual GIP and GLP-1 target that’s showing impressive results in here early trials . This compound works by mimicking natural hormones to regulate appetite and boost feelings of satiety, ultimately contributing to substantial weight decrease. While presently under review and not broadl